In vivo imaging to understand the biodistribution of a candidate compound

How imaging technologies can be used to establish the biodistribution and accumulation of the compounds in vivo

Juliana Maynard is Lead Scientist in Pre-clinical Imaging at MDC. She works with a wide range of molecular imaging modalities including PET, SPECT, CT and ultrasound. Previously she was Head of Imaging Services at Alderley Imaging and worked at AstraZeneca for 9 years. Juliana has a PHD in neuroendocrinology from the University of Edinburgh.